EUVIMEDEUVIMED entdecken
Crossref

Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer

Haibin Lu, Weifang Tong, Meixu Jiang, Huimin Liu, Chen Meng, Kai Wang, Xupeng Mu iD

ACS Nano · 13.08.2024 · 18 (32) · 21156-21170

DOI: 10.1021/acsnano.4c04024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 01.08.2024. Verfasst von Haibin Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jilin University School of Pharmaceutical Sciences, Changchun 130021, China. Hauptthemen laut MEDLINE: Cisplatin, Mitochondria, Antineoplastic Agents, Lung Neoplasms. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinMitochondriaAntineoplastic AgentsLung NeoplasmsDrug Resistance, NeoplasmProdrugsHumansNanoparticlesAnimalsMiceDrug Delivery SystemsCell ProliferationDrug Screening Assays, AntitumorCell Line, TumorMetabolic Reprogramming

Stichwörter der Autor:innen

cisplatinglutathioneglycolysismitochondrialoxidative phosphorylationtriphenylphosphine group

Substanzen

CisplatinAntineoplastic AgentsProdrugs

Autor:innen und Institutionen

  • Jilin University School of Pharmaceutical Sciences, Changchun 130021, China.
  • Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, Changchun 130041, China.
  • Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun 130033, China.

ORCID-Profile: Xupeng Mu

Förderung

  • Jilin Provincial Scientific and Technological Development Program

Zitieren

APA

Lu, H., Tong, W., Jiang, M., Liu, H., Meng, C., Wang, K., & Mu, X. (2024). Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer. ACS Nano, 18(32), 21156-21170. https://doi.org/10.1021/acsnano.4c04024

Vancouver

Lu H, Tong W, Jiang M, Liu H, Meng C, Wang K, et al. Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer. ACS Nano. 2024;18(32):21156-21170. doi:10.1021/acsnano.4c04024

BibTeX
@article{Lu2024,
  author = {Lu, Haibin and Tong, Weifang and Jiang, Meixu and Liu, Huimin and Meng, Chen and Wang, Kai and Mu, Xupeng},
  title = {Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {32},
  pages = {21156--21170},
  doi = {10.1021/acsnano.4c04024}
}
Kostenlos starten →